positionForPages[46]={page:46,positions:[{w:"36",p:[0.021502,0.039294,0.047607,0.039294,0.047607,0.019261,0.021502,0.019261,0.000000,0.000000]},{w:"TreaTmenT approaches",p:[0.097208,0.039084,0.362685,0.039084,0.362685,0.019649,0.097208,0.019649,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS ",p:[0.097141,0.974259,0.701335,0.974259,0.701335,0.960936,0.097141,0.960936,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.701335,0.974259,0.705081,0.974259,0.705081,0.960936,0.701335,0.960936,0.000000]},{w:"VOLUME 1",p:[0.705252,0.974259,0.786566,0.974259,0.786566,0.959690,0.705252,0.959690,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Table 5. Hybrid approach for optimising  ",p:[0.096970,0.096562,0.444391,0.096562,0.444391,0.080172,0.096970,0.080172,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"the duration of anticoagulation in patients ",p:[0.096970,0.112001,0.463961,0.112001,0.463961,0.095610,0.096970,0.095610,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"with VTE  ",p:[0.096970,0.127439,0.179596,0.127439,0.179596,0.111048,0.096970,0.111048,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"acute pe  ",p:[0.255357,0.154676,0.325229,0.154676,0.325229,0.140541,0.255357,0.140541,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"or DVT",p:[0.262353,0.167905,0.310963,0.167905,0.310963,0.153771,0.262353,0.153771,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"\\Grey zone\\",p:[0.245231,0.218740,0.328085,0.218740,0.328085,0.204606,0.245231,0.204606,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"individualise ",p:[0.241503,0.278183,0.335457,0.278183,0.335457,0.264049,0.241503,0.264049,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"treatment ",p:[0.250961,0.291413,0.325998,0.291413,0.325998,0.277278,0.250961,0.277278,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"strategy",p:[0.257735,0.304642,0.315599,0.304642,0.315599,0.290507,0.257735,0.290507,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"consider past/family VTe history, gender,  ",p:[0.141254,0.362556,0.438733,0.362556,0.438733,0.348422,0.141254,0.348422,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"presenting symptoms of pe versus DVT, ",p:[0.146488,0.375785,0.429873,0.375785,0.429873,0.361651,0.146488,0.361651,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"recanalisation of leg veins on ultrasound, ",p:[0.141066,0.389015,0.435295,0.389015,0.435295,0.374880,0.141066,0.374880,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"hypercoagulability work-up, patient preference",p:[0.118967,0.402244,0.453768,0.402244,0.453768,0.388109,0.118967,0.388109,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"provoked",p:[0.119737,0.218740,0.186940,0.218740,0.186940,0.204606,0.119737,0.204606,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"3-6 months  ",p:[0.112621,0.278183,0.201307,0.278183,0.201307,0.264049,0.112621,0.264049,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"of ",p:[0.146146,0.291413,0.164157,0.291413,0.164157,0.277278,0.146146,0.277278,0.000000,0.000000,0.000000]},{w:"anticoagulation",p:[0.103197,0.304642,0.203497,0.304642,0.203497,0.290507,0.103197,0.290507,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"idiopathic",p:[0.382118,0.218740,0.453973,0.218740,0.453973,0.204606,0.382118,0.204606,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"consider ",p:[0.387967,0.270611,0.454794,0.270611,0.454794,0.256476,0.387967,0.256476,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"indefinite ",p:[0.385436,0.283840,0.457343,0.283840,0.457343,0.269705,0.385436,0.269705,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"duration ",p:[0.388925,0.297069,0.453853,0.297069,0.453853,0.282934,0.388925,0.282934,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"anticoagulation",p:[0.368229,0.310298,0.470923,0.310298,0.470923,0.296163,0.368229,0.296163,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Patients with extended treatment beyond acute ",p:[0.115151,0.447257,0.480006,0.447257,0.480006,0.432268,0.115151,0.432268,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"therapy may continue with apixiban 2,5 mg twice ",p:[0.096967,0.465050,0.479987,0.465050,0.479987,0.450062,0.096967,0.450062,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"daily or rivaroxaban 10 mg once daily. both these ",p:[0.096967,0.482843,0.480006,0.482843,0.480006,0.467855,0.096967,0.467855,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"drugs are effective in preventing vte recurrence ",p:[0.096967,0.500637,0.479968,0.500637,0.479968,0.485648,0.096967,0.485648,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"with no risk of increased bleeding, compared to ",p:[0.096967,0.518430,0.479987,0.518430,0.479987,0.503441,0.096967,0.503441,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"vKa if there are cost limitations. ",p:[0.096967,0.536223,0.341384,0.536223,0.341384,0.521234,0.096967,0.521234,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"REFERENCES",p:[0.524437,0.096565,0.637082,0.096565,0.637082,0.080174,0.524437,0.080174,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"1.   Kruger  P, ",p:[0.524242,0.110378,0.618607,0.110378,0.618607,0.097054,0.524242,0.097054,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.623156,0.110378,0.655689,0.110378,0.655689,0.097290,0.623156,0.097290,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"  deep vein thrombosis:  update on ",p:[0.655347,0.110378,0.906764,0.110378,0.906764,0.097054,0.655347,0.097054,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"diagnosis and management. ",p:[0.554534,0.124559,0.751405,0.124559,0.751405,0.111236,0.554534,0.111236,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Med J Aust",p:[0.754809,0.124559,0.827382,0.124559,0.827382,0.111471,0.754809,0.111471,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" . 2019;210 ",p:[0.827040,0.124559,0.906729,0.124559,0.906729,0.111236,0.827040,0.111236,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"(11):doi:10.5694/mja2.50201 Published online: 17 June ",p:[0.554534,0.138741,0.906798,0.138741,0.906798,0.125418,0.554534,0.125418,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"2019.",p:[0.554534,0.152923,0.589529,0.152923,0.589529,0.139599,0.554534,0.139599,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"2.   Farge  d, ",p:[0.524225,0.167104,0.616144,0.167104,0.616144,0.153781,0.524225,0.153781,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.620625,0.167104,0.653807,0.167104,0.653807,0.154016,0.620625,0.154016,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2019 International clinical practice ",p:[0.653636,0.167104,0.906781,0.167104,0.906781,0.153781,0.653636,0.153781,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"guidelines for the treatment and prophylaxis of ",p:[0.554534,0.181286,0.906747,0.181286,0.906747,0.167963,0.554534,0.167963,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"vte in  patients with  cancer.  Published online ",p:[0.554534,0.195468,0.906764,0.195468,0.906764,0.182144,0.554534,0.182144,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.903018,0.195468,0.906764,0.195468,0.906764,0.182144,0.903018,0.182144,0.000000]},{w:"3 September 2019.",p:[0.554534,0.209649,0.680028,0.209649,0.680028,0.196326,0.554534,0.196326,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"3.   Scovell S. Phlebitis and thrombosis of the superficial ",p:[0.524225,0.223831,0.906815,0.223831,0.906815,0.210508,0.524225,0.210508,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"lower extremity veins. ",p:[0.554534,0.238013,0.707908,0.238013,0.707908,0.224689,0.554534,0.224689,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Up to Date.",p:[0.710235,0.238013,0.785836,0.238013,0.785836,0.224925,0.710235,0.224925,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 3 october 2019. ",p:[0.785665,0.238013,0.906764,0.238013,0.906764,0.224689,0.785665,0.224689,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"https://www.uptodate.com/contents/phlebitis-  ",p:[0.554534,0.252194,0.906764,0.252194,0.906764,0.238871,0.554534,0.238871,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"and-thrombosis-of-the-superficial-lower-extremity-",p:[0.554534,0.266376,0.903001,0.266376,0.903001,0.253053,0.554534,0.253053,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"veins.",p:[0.554534,0.280558,0.591496,0.280558,0.591496,0.267234,0.554534,0.267234,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"4.   Suresh  v, Piazza G,  neil  a. Guidance for the use ",p:[0.524225,0.294739,0.906832,0.294739,0.906832,0.281416,0.524225,0.281416,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"of thrombolytic therapy for the treatment of ",p:[0.554534,0.308921,0.906798,0.308921,0.906798,0.295598,0.554534,0.295598,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"venous thromboembolism. ",p:[0.554534,0.323103,0.743879,0.323103,0.743879,0.309779,0.554534,0.309779,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"J Thromb Thrombolysis.",p:[0.747488,0.323103,0.903018,0.323103,0.903018,0.310015,0.747488,0.310015,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.903018,0.323103,0.906764,0.323103,0.906764,0.309779,0.903018,0.309779,0.000000]},{w:"2016;41:68-80. www.ncbi.nlm.nih.gov/PMC4715849/ ",p:[0.554534,0.337284,0.906764,0.337284,0.906764,0.323961,0.554534,0.323961,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"5.   Young  e, Minocha J. Inferior vena cava filters: ",p:[0.524225,0.351466,0.906747,0.351466,0.906747,0.338143,0.524225,0.338143,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Guidelines, best practice and expanding indications. ",p:[0.554534,0.365648,0.906781,0.365648,0.906781,0.352324,0.554534,0.352324,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Semin Intervent Radiol.",p:[0.554534,0.379829,0.701751,0.379829,0.701751,0.366741,0.554534,0.366741,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2016 Jun;33(2) 65-70. https://",p:[0.701580,0.379829,0.902984,0.379829,0.902984,0.366506,0.701580,0.366506,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"www.ncbi.nlm.nih.gov/pmc/articles/PMC4862857/",p:[0.554534,0.394011,0.893251,0.394011,0.893251,0.380688,0.554534,0.380688,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"6.   Goldhaber SZ.  optimal duration of anticoagulation ",p:[0.524225,0.408193,0.906781,0.408193,0.906781,0.394869,0.524225,0.394869,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"after venous thromboembolism. ",p:[0.554534,0.422374,0.784074,0.422374,0.784074,0.409051,0.554534,0.409051,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Circulation.",p:[0.789069,0.422374,0.861574,0.422374,0.861574,0.409286,0.789069,0.409286,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2011 ",p:[0.861403,0.422374,0.906764,0.422374,0.906764,0.409051,0.861403,0.409051,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Feb;123(6):664-667. https://www.throm bosisadviser.",p:[0.554534,0.436556,0.903018,0.436556,0.903018,0.423233,0.554534,0.423233,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"com/extended-vte-treatment-how-long-to-treat/",p:[0.554534,0.450738,0.886837,0.450738,0.886837,0.437414,0.554534,0.437414,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"7.   Czernik  W, Cumbler P. Should patients with an ",p:[0.524225,0.464919,0.906747,0.464919,0.906747,0.451596,0.524225,0.451596,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"unprovoked  vte be screened for malignancy or a ",p:[0.554534,0.479101,0.906781,0.479101,0.906781,0.465778,0.554534,0.465778,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"hypercoagulable state? ",p:[0.554534,0.493283,0.706968,0.493283,0.706968,0.479959,0.554534,0.479959,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"The Hospitalist.",p:[0.704932,0.493283,0.796577,0.493283,0.796577,0.480195,0.704932,0.480195,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2014 december; ",p:[0.796235,0.493283,0.906764,0.493283,0.906764,0.479959,0.796235,0.479959,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"(12). https://www.the-hospitalist.org/hospitalist/article/ ",p:[0.554534,0.507464,0.906764,0.507464,0.906764,0.494141,0.554534,0.494141,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"122690/should-patients-unprovoked-vte-be-screened-",p:[0.554534,0.521646,0.903138,0.521646,0.903138,0.508323,0.554534,0.508323,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"malignancy-or-hypercoagulable",p:[0.554534,0.535828,0.759187,0.535828,0.759187,0.522504,0.554534,0.522504,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]}]};